First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination (T plus L) in the adjuvant treatment of HER2-positive early breast cancer (EBC) Meeting Abstract
| Authors: | Piccart-Gebhart, M. J.; Holmes, A. P.; Baselga, J.; de Azambuja, E.; Dueck, A. C.; Viale, G.; Zujewski, J. A.; Goldhirsch, A.; Santillana, S.; Pritchard, K. I.; Wolff, A. C.; Jackisch, C.; Lang, I.; Untch, M.; Smith, I. E.; Boyle, F.; Xu, B. H.; Gomez, H. L.; Gelber, R. D.; Perez, E. A. |
| Abstract Title: | First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination (T plus L) in the adjuvant treatment of HER2-positive early breast cancer (EBC) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613201956 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.LBA4 |
| Notes: | Meeting Abstract: LBA4 -- Source: Wos |
